0001193125-22-100388.txt : 20220408 0001193125-22-100388.hdr.sgml : 20220408 20220408163036 ACCESSION NUMBER: 0001193125-22-100388 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220406 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20220408 DATE AS OF CHANGE: 20220408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Prelude Therapeutics Inc CENTRAL INDEX KEY: 0001678660 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811384762 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39527 FILM NUMBER: 22817410 BUSINESS ADDRESS: STREET 1: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: (302) 547-3768 MAIL ADDRESS: STREET 1: 200 POWDER MILL ROAD CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: Prelude Therapeutics Inc. DATE OF NAME CHANGE: 20160630 8-K 1 d292059d8k.htm 8-K 8-K
Prelude Therapeutics Inc false 0001678660 0001678660 2022-04-06 2022-04-06

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 6, 2022

 

 

Prelude Therapeutics Incorporated

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-39527   81-1384762
(State or other jurisdiction of
incorporation or organization)		   (Commission
File Number)		   (I.R.S. Employer
Identification No.)

 

200 Powder Mill Road

Wilmington, Delaware

   19803
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (302) 467-1280

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.0001 par value per share   PRLD   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 6, 2022 (the “Effective Date”), Prelude Therapeutics Incorporated (the “Company”) and Deborah Morosini, the Company’s EVP and Chief of Clinical Affairs, agreed that, effective as of the Effective Date, Dr. Morosini shall resign from her role as an officer of the Company and will transition into a role of Strategic Advisor to the President from the Effective Date until May 5, 2022, upon which Dr. Morosini’s employment with the Company shall terminate (the “Separation Date”).

In connection with her resignation, Dr. Morosini will receive (i) severance payments equal to three months of her base salary, (ii) payment for three months of Consolidated Omnibus Budget Reconciliation Act (COBRA) premiums, and (iii) will provide consulting services to the Company on an as needed basis from the Separation Date until November 4, 2022, unless such services are earlier terminated.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PRELUDE THERAPEUTICS INCORPORATED
Date: April 8, 2022   By:  

/s/ Laurent Chardonnet

    Laurent Chardonnet
    Chief Financial Officer
 EX-101.SCH 2 prld-20220406.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 prld-20220406_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 prld-20220406_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
Apr. 06, 2022
Cover [Abstract]  
Entity Registrant Name Prelude Therapeutics Inc
Amendment Flag false
Entity Central Index Key 0001678660
Document Type 8-K
Document Period End Date Apr. 06, 2022
Entity Incorporation State Country Code DE
Entity File Number 001-39527
Entity Tax Identification Number 81-1384762
Entity Address, Address Line One 200 Powder Mill Road
Entity Address, City or Town Wilmington
Entity Address, State or Province DE
Entity Address, Postal Zip Code 19803
City Area Code (302)
Local Phone Number 467-1280
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol PRLD
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
XML 6 d292059d8k_htm.xml IDEA: XBRL DOCUMENT 0001678660 2022-04-06 2022-04-06 Prelude Therapeutics Inc false 0001678660 8-K 2022-04-06 DE 001-39527 81-1384762 200 Powder Mill Road Wilmington DE 19803 (302) 467-1280 false false false false Common Stock, $0.0001 par value per share PRLD NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d292059d8k.htm prld-20220406.xsd prld-20220406_lab.xml prld-20220406_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d292059d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d292059d8k.htm" ] }, "labelLink": { "local": [ "prld-20220406_lab.xml" ] }, "presentationLink": { "local": [ "prld-20220406_pre.xml" ] }, "schema": { "local": [ "prld-20220406.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "prld", "nsuri": "http://preludetx.com/20220406", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d292059d8k.htm", "contextRef": "duration_2022-04-06_to_2022-04-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d292059d8k.htm", "contextRef": "duration_2022-04-06_to_2022-04-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://preludetx.com//20220406/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 14 0001193125-22-100388-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-100388-xbrl.zip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